ASSURE Wearable ECG vs AVIEW Lung Nodule CAD
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A, the ASSURE Wearable ECG, is designed for continuous, remote cardiac monitoring of heart rate and rhythm for at-risk patients. In contrast, Tool B, AVIEW Lung Nodule CAD, is an AI-powered software that assists radiologists in analyzing chest CT scans for lung nodules, emphysema, and coronary artery calcification. While both offer insights relevant to cardiac health, their distinct modalities and primary applications mean they serve different clinical workflows and patient needs.
Choose ASSURE Wearable ECG if…
Choose ASSURE Wearable ECG if your primary need is continuous, long-term, remote monitoring of cardiac patients to capture intermittent or asymptomatic heart rate abnormalities. This tool is ideal for managing at-risk individuals outside of a clinical setting, providing clinicians with real-time alerts and trend data for proactive intervention.
View ASSURE Wearable ECG →Choose AVIEW Lung Nodule CAD if…
Choose AVIEW Lung Nodule CAD if your radiology department requires AI-powered assistance for the efficient and accurate detection and analysis of pulmonary nodules on chest CT scans. This solution is best suited for enhancing lung cancer screening programs and providing comprehensive quantitative assessment of emphysema and coronary artery calcification.
View AVIEW Lung Nodule CAD →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | ASSURE Wearable ECG | AVIEW Lung Nodule CAD |
|---|---|---|
| Deployment | The ASSURE system is intended for use by a patient during their normal daily activities primarily in the home or community setting, but also hospitals, medical clinics, healthcare facilities and transport. | On-premises and cloud environment |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | ASSURE Wearable ECG | AVIEW Lung Nodule CAD |
|---|---|---|
| Product Name | ASSURE Wearable ECG | AVIEW Lung Nodule CAD |
| Company | Kestra Medical Technologies | Coreline Soft Co. |
| Primary Function | Non-therapeutic device for continuous heart rate monitoring and data collection for at-risk cardiac patients. | AI-powered software assisting radiologists in detecting and analyzing pulmonary nodules on chest CT scans, and offering comprehensive screening for lung cancer, COPD, and coronary artery calcification. |
| Key Application Area(s) | Cardiology | Cardiology, Pulmonology, Radiology |
| Specific Detection/Monitoring | Continuous heart rate monitoring via wearable ECG device; ASSURE Detection Algorithm with Quad Channel Processingu2122; Adaptive Patient Intelligenceu2122 for filtering motion artifacts. | AI-based pulmonary nodule detection (3-20 mm) on CT scans; Nodule classification (solid, part-solid, non-solid); Simultaneous analysis of lung nodules, emphysema, and coronary artery calcification (Big 3). |
| Data Analysis/Reporting | Automatic episode storage; Alert-based notifications; Physiologic trend data; Kestra CareStation remote patient data platform for clinician review. | 3D nodule size and volume quantification; Automatic report generation based on Lung-RADS classification; Nodule matching and volume doubling time (VDT) calculation for follow-up comparisons; Quantitative emphysema analysis; Coronary Artery Calcification (CAC) scoring. |
Videos
Demos, reviews, and walkthroughs featuring ASSURE Wearable ECG and AVIEW Lung Nodule CAD.
Loading videos…
Videos need JavaScript to load. Search YouTube directly →
Frequently Asked Questions
The ASSURE Wearable ECG is a non-therapeutic device designed for continuous heart rate monitoring and data collection for at-risk cardiac patients. In contrast, AVIEW Lung Nodule CAD is an AI-powered software that assists radiologists in detecting and analyzing pulmonary nodules on chest CT scans, also offering comprehensive screening for lung cancer, COPD, and coronary artery calcification.
The ASSURE Wearable ECG provides continuous heart rate monitoring, automatic episode storage, alert-based notifications, and physiologic trend data for clinician review via the Kestra CareStation remote patient data platform. AVIEW Lung Nodule CAD offers AI-based pulmonary nodule detection (3-20 mm), classification (solid, part-solid, non-solid), 3D size and volume quantification, automatic report generation based on Lung-RADS classification, and quantitative analysis of emphysema and coronary artery calcification.
The ASSURE Wearable ECG is primarily designed for Cardiology. AVIEW Lung Nodule CAD supports Cardiology, Pulmonology, and Radiology specialties.
The ASSURE Wearable ECG utilizes a wearable device with non-adhesive, embedded ECG sensors and a proprietary ASSURE Detection Algorithm with Quad Channel Processing and Adaptive Patient Intelligence for continuous cardiac monitoring. AVIEW Lung Nodule CAD is an AI-powered software that analyzes chest CT scans using deep learning to detect and characterize lung nodules, and simultaneously analyze emphysema and coronary artery calcification.